Researchers, Health Experts Are Smothered Under FDA Restrictions On Marijuana
Share
“It’s ridiculous,” Steven Greenhut, Western Region director for the R Street Institute, told The Daily Caller News Foundation. “Having it as a Schedule I drug makes it impossible to do the serious research needed to determine what the effects are so it can be a more effective medical tool.”
Featured Publications
Treat your sweetheart right this Valentine’s Day by avoiding corn-sweetened candies
Safer Solutions Part III: A Valentine’s Day Reminder that STIs CAN Happen to You
Low-Energy Fridays: Do we want energy independence or energy security?
ATC’s “Beggar Thy Neighbor” Strategy on Electric Transmission
Language Matters: Defining Death in the Age of Fentanyl